Esomeprazole Magnesium
Product Images NDC 68788-8431

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68788-8431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Dr Capsules 20mg (6c70018b D2f6 409e A493 78f7e61367f4 00)

Esomeprazole Magnesium Dr Capsules 20mg (6c70018b D2f6 409e A493 78f7e61367f4 00)
This is a description of a drug called Esomeprazole Magnesium DR. The drug comes in a capsule with a delayed-release formula that contains 20mg of Esomeprazole magnesium dihydrate USP eq. It is used to treat certain stomach and esophagus problems. The label cautions against transferring the drug to anyone other than the patient for whom it was prescribed. The drug should be kept out of the reach of children and is only available by prescription. The manufacturer and batch number information is also provided. No information is provided about Chart Log or Billing, so it is assumed to be not relevant.*
FDA Label Image

Figure 2: Maintenance Of Healing Rates Of Ee In Adults By Month (study 177) (Esomeprazole Fig1)

FDA Label Image

Figure 3: Maintenance Of Ee Healing Rates In Adults By Month (study 178) (Esomeprazole Fig2)

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)
This appears to be a graph showing the effectiveness of two different doses of Esomeprazole Magnesium Delayed-Release Capsules (40mg and 20mg) compared to a placebo in treating symptoms in patients. The vertical axis measures the percentage of patients who are symptom-free, with 100% being the highest point. The horizontal axis appears to show the progression of time over 21 days, with data points recorded on Day 7, Day 14, and Day 21 of the study.*
FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)
This text represents the percentage of patients who were symptom-free after taking Esomeprazole Magnesium Delayed-Release Capsules in two different doses (20mg and 40mg) compared to a placebo. However, without any context or further information, it's unclear what symptoms were being treated and what the study design was.*
FDA Label Image

Chemical Structure (Esomeprazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.